Premium
Innovative use of concentrated growth factors combined with corticosteroids to treat discoid lupus erythematosus alopecia: A case report
Author(s) -
Fang Huijuan,
Liu Qingwu,
Cheng Tiantian,
Yang Chaowei,
Wu Ruiying,
Yang Zhishan,
Yang Dingquan
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13904
Subject(s) - discoid lupus erythematosus , medicine , dermatology , histiocyte , regeneration (biology) , refractory (planetary science) , hair growth , lupus erythematosus , systemic lupus erythematosus , scarring alopecia , immunology , disease , pathology , antibody , scalp , biology , physiology , astrobiology , microbiology and biotechnology
Alopecia for patients with discoid lupus erythematosus can sometimes be a refractory condition, where mixed infiltrates of T lymphocytes and histiocytes leads to destruction of hair follicles, which might cause permanent scarring. Early diagnosis and timely treatment can achieve hair regeneration and prevent further disease progression. Concentrated growth factor, a novel autologous plasma extract, contains various growth factors that could promote tissue regeneration. In this article, we report a case of cell growth factor combined with corticosteroids for the treatment of discoid lupus erythematosus alopecia. This case study concludes with satisfactory clinical effect.